Will DD achieve at least 3% organic revenue growth in FY2026?

DuPont achieved 2% organic growth in FY2025 and guided 3% for FY2026, which aligns with the Investor Day medium-term framework of 3-4% organic growth. Healthcare & Water Technologies growing mid-single digits (~48% of revenue) provides the growth engine. If Healthcare grows 5% and Diversified Industrials grows 1% (above guided flat due to some recovery in non-construction segments), the blended rate would be ~3%. Management raised EBITDA guidance mid-year in FY2025, suggesting conservative initial targets. The 30% vitality index and $2B in new product revenue provide organic growth support. However, construction weakness in Building Technologies and macro uncertainty in APAC create real downside risk to the 3% target.

The math is tight. Healthcare at ~48% growing 5% contributes ~2.4pp. Diversified Industrials at ~52% needs to contribute at least 0.6pp, implying ~1.2% growth. With Building Technologies guided flat and potentially still declining, the Industrial Technologies sub-segment would need to carry the load. Aerospace and automotive/EV exposure provide positive secular trends, but the ~30% APAC exposure introduces macro risk. The 3% target is achievable in a stable macro environment but not guaranteed. Management's track record of meeting growth targets (2% guided, 2% delivered in FY2025) suggests they calibrate guidance to what they can deliver.

Several tailwinds support achieving the 3% target: (1) the Investor Day framework of 3-4% was set after careful analysis, (2) management guidance has been conservative historically, (3) 125 new products with $2B in new product sales provide genuine organic growth drivers, (4) water filtration demand is accelerating with EPA PFAS regulations creating structural tailwind for the Water Technologies business. The main risk is construction, but even with Building Technologies flat, the rest of the portfolio should generate sufficient growth. Probability slightly above coin-flip, leaning YES.

Management guided 3% organic growth after delivering 2% in FY2025, with the Investor Day framework calling for 3-4%. The guidance raise implies confidence in acceleration. Healthcare & Water Technologies should sustain mid-single-digit growth on secular tailwinds (medical device demand, water filtration). The key risk is Diversified Industrials — if construction weakness deepens rather than stabilizes, the blended rate could fall below 3%. But management has been a reliable forecaster (met 2% target in FY2025), and the 3% target was set after the Investor Day analysis. Slightly above coin-flip.

The 3% target is on the edge. Healthcare at mid-single digits is supportive, but Diversified Industrials at 52% of revenue being flat/declining creates significant headwind. If Building Technologies declines rather than staying flat (which is possible given residential construction trending down low-to-mid single digits), the blended rate may fall just short. The CONDITIONAL revenue durability classification reflects this segment divergence risk. True coin-flip — the target is achievable but not assured.

Management's conservative guidance pattern and the Investor Day framework both support the 3% target being achievable. The new product pipeline (30% vitality, 125 launches) provides organic growth independent of end market conditions. The question is whether these incremental growth drivers can offset macro headwinds. Given management's track record and the structural growth in healthcare/water, probability is slightly above 50% but with meaningful uncertainty.

Management guided 3% after delivering 2% in FY2025. Healthcare growth mid-single digits is the engine. Construction weakness is the risk. Investor Day framework suggests management confidence. Slightly above coin-flip.

The 3% target is achievable if Healthcare performs as expected and Industrials holds flat. But the margin for error is thin. Construction down further or APAC softness could push result to 2.5%. Near coin-flip leaning slightly YES based on management guidance credibility.

New product launches and water filtration tailwinds provide growth support beyond end market conditions. Management set this target at Investor Day with full visibility. Healthcare growth is reliable. Construction is the swing factor but guided flat, not further decline. Probability moderately above coin-flip.